| Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy (NCT05349357) | Riphah International University | 2022-06-25 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain (NCT05177094) | Eli Lilly and Company | 2022-01-26 |
| Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy (NCT05521737) | Instituto Mexicano del Seguro Social | 2021-11-01 |
| The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain. (NCT04953221) | Peking University Third Hospital | 2021-07-01 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain (NCT04707157) | Eli Lilly and Company | 2021-05-06 |
| rTMS on Diabetic Peripheral Neuropathic Pain (NCT04833660) | Min Cheol Chang | 2021-04-30 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain (NCT04647773) | Haisco Pharmaceutical Group Co., Ltd. | 2020-12-02 |
| Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain (NCT04688671) | Eliem Therapeutics (UK) Ltd. | 2020-11-09 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain (NCT04476108) | Eli Lilly and Company | 2020-07-15 |
| Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN) (NCT04146896) | Aptinyx | 2019-11-12 |
| A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain (NCT04094662) | Daiichi Sankyo Co., Ltd. | 2019-09-18 |
| Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition (NCT03909841) | Queen Elizabeth Hospital, Hong Kong | 2017-06-01 |
| Transcutaneous Pulsed Radiofrequency for the Treatment of Diabetic Peripheral Neuropathy Pain (NCT07725419) | Algiamed Technologies USA, Inc. | 2016-12-01 |
| DS-5565 Phase III Study for Renal Impairment in Japanese Subjects (NCT02607280) | Daiichi Sankyo Co., Ltd. | 2015-12-01 |
| A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP) (NCT02417935) | Eli Lilly and Company | 2015-04-01 |
| Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients (NCT02345291) | Novaremed Ltd. | 2015-04-01 |
| DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain (NCT02318706) | Daiichi Sankyo Co., Ltd. | 2015-01-01 |
| Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) (NCT02156336) | Horizons International Peripheral Group | 2014-05-01 |
| Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain (NCT01429181) | MetaPharm, Inc. | 2012-01-01 |
| Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management (NCT01364298) | Merck KGaA, Darmstadt, Germany | 2011-04-01 |
| Diabetic Peripheral Neuropathic Pain (DPNP) (NCT01314222) | Bristol-Myers Squibb | 2011-03-01 |
| Cognitive Behavioral Therapy for Diabetic Neuropathic Pain (NCT00829387) | VA Connecticut Healthcare System | 2010-03-01 |
| Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain (NCT00838799) | Forest Laboratories | 2009-02-01 |
| Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain (NCT00794430) | Vernalis (R&D) Ltd | 2008-12-01 |
| Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial (NCT00071708) | Eli Lilly and Company | |